Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Common Sense should prevail

<< Previous

Bullboard Posts

Next >>

Comment by MoneyMouthon Jun 11, 2021 1:03pm

155 Views

Post# 33372915

RE:RE:Common Sense should prevail

Well for thyroid they completed preclinical work and are working on the regulatory package, they also have established their clinical investigator. All of this has been communicated through their video presentations

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China